Intensity Therapeutics (INTS) Shares Issued (2022 - 2023)
Intensity Therapeutics' (INTS) quarterly Shares Issued came in at $801750.0 in Q3 2023, up 148.03% YoY from $323250.0 in Q3 2022, and up 21.34% on a QoQ basis from $660750.0 in Q2 2023.
Intensity Therapeutics (INTS) Shares Issued (2022 - 2023) Analysis & Trends
Intensity Therapeutics (INTS) has 2 years of Shares Issued data on file, last reported at $801750.0 in Q3 2023.
- Quarterly Shares Issued rose 148.03% year-over-year to $801750.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $801750.0 (up 148.03% YoY) and the FY2022 annual result came in at $357750.0, changed N/A from the prior year.
- Shares Issued advanced to $801750.0 in Q3 2023, from $660750.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $801750.0 in Q3 2023 to a low of $323250.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Intensity Therapeutics | 13.06 Mn | 13.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 801,750.00 |
| Sep 30, 2023 | 801,750.00 |
| Jun 30, 2023 | 660,750.00 |
| Jun 30, 2023 | 660,750.00 |
| Mar 31, 2023 | 387,750.00 |
| Mar 31, 2023 | 387,750.00 |
| Dec 31, 2022 | 357,750.00 |
| Dec 31, 2022 | 357,750.00 |
| Sep 30, 2022 | 323,250.00 |
| Sep 30, 2022 | 323,250.00 |
| Jun 30, 2022 | 323,250.00 |
| Jun 30, 2022 | 323,250.00 |